A genomic operating system to combat infectious diseases

Antibiotic resistance is a leading health threat, and whole genome sequencing is the most accurate way to study pathogens. We make it easier to understand, detect and prevent the spread of antibiotic resistance.
Solu's founding team sitting on sofas, looking at a laptop.researchers sitting together and smilingmicrobiologist and doctor looking at Solu's software on their screensmicrobiologist on a field trip, looking to the sky

Our story

Solu was founded in 2022 with a mission to revolutionize the world of bacterial DNA analysis. We are headquartered in Helsinki, Finland.

Solu raised a pre-seed financing round in early 2023, led by Lifeline Ventures.

Solu's founding team sitting on sofas, looking at a laptop.

We work with leading researchers

We work with leading medical professionals, researchers, and universities to uncover new insights into microbes that can enable new diagnostics, therapies and health policies.

researchers sitting together and smiling

For a better future

Our technology has potential to avoid unnecessary deaths from resistant infections. With better understanding of pathogens, faster diagnostics, and robust surveillance, Solu paves the way for developing new therapies, such as antibiotics, bacteriophages and antitoxin agents.

microbiologist and doctor looking at Solu's software on their screens

Join the journey

Our team is passionate about making genomics accessible and we want to partner with you to create a better future for healthcare. Let's work together to tackle antibiotic resistance and improve global health.

Book a meeting
biologist on a field trip, looking to the sky

In the press

Founding team

Sam Sihvonen, co-founder of Solu
Sam Sihvonen
Co-founder & CEO
Formerly clinical research at Meru Health
Timo Moilanen, co-founder of Solu
Timo Moilanen
Co-founder, Technology
Previously data science at Upright project.
Kerkko Visuri, co-founder of Solu
Kerkko Visuri
Co-founder, Product
Formerly Wolt & BCG